Trial intelligence / Profile preview

ESP Block for Postoperative Analgesia in Pediatric Cardiac Surgery

NCT03627897Phase 4Completed

Sponsor
Cukurova University
Start
Aug 2019
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Cukurova University. Primary endpoint: Total Morphine Consumption at 24 hours. Started Aug 2019; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03627897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03627897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call